JACNX vs. JNGLX
Compare and contrast key facts about Janus Henderson Contrarian Fund (JACNX) and Janus Henderson Global Life Sciences Fund (JNGLX).
JACNX is managed by Janus Henderson. It was launched on Feb 29, 2000. JNGLX is managed by Janus Henderson. It was launched on Dec 30, 1998.
Performance
JACNX vs. JNGLX - Performance Comparison
Loading graphics...
JACNX vs. JNGLX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
JACNX Janus Henderson Contrarian Fund | -4.88% | 7.34% | 18.44% | 21.58% | -21.54% | 20.79% | 27.88% | 43.19% | -4.08% | 5.00% |
JNGLX Janus Henderson Global Life Sciences Fund | -3.73% | 24.84% | 3.60% | 7.51% | -2.69% | 6.78% | 25.66% | 29.20% | 4.17% | 22.13% |
Returns By Period
In the year-to-date period, JACNX achieves a -4.88% return, which is significantly lower than JNGLX's -3.73% return. Both investments have delivered pretty close results over the past 10 years, with JACNX having a 11.16% annualized return and JNGLX not far behind at 11.02%.
JACNX
- 1D
- 4.46%
- 1M
- -5.80%
- YTD
- -4.88%
- 6M
- -8.56%
- 1Y
- 10.22%
- 3Y*
- 10.38%
- 5Y*
- 5.25%
- 10Y*
- 11.16%
JNGLX
- 1D
- 3.08%
- 1M
- -5.55%
- YTD
- -3.73%
- 6M
- 11.88%
- 1Y
- 21.71%
- 3Y*
- 10.69%
- 5Y*
- 7.33%
- 10Y*
- 11.02%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
JACNX vs. JNGLX - Expense Ratio Comparison
JACNX has a 0.90% expense ratio, which is higher than JNGLX's 0.80% expense ratio.
Return for Risk
JACNX vs. JNGLX — Risk / Return Rank
JACNX
JNGLX
JACNX vs. JNGLX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Janus Henderson Contrarian Fund (JACNX) and Janus Henderson Global Life Sciences Fund (JNGLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| JACNX | JNGLX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.41 | 1.07 | -0.66 |
Sortino ratioReturn per unit of downside risk | 0.76 | 1.54 | -0.78 |
Omega ratioGain probability vs. loss probability | 1.10 | 1.20 | -0.10 |
Calmar ratioReturn relative to maximum drawdown | 0.67 | 1.80 | -1.13 |
Martin ratioReturn relative to average drawdown | 1.94 | 4.97 | -3.03 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| JACNX | JNGLX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.41 | 1.07 | -0.66 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.24 | 0.47 | -0.23 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.52 | 0.63 | -0.12 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.33 | 0.57 | -0.24 |
Correlation
The correlation between JACNX and JNGLX is 0.69, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
JACNX vs. JNGLX - Dividend Comparison
JACNX's dividend yield for the trailing twelve months is around 11.67%, more than JNGLX's 4.74% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JACNX Janus Henderson Contrarian Fund | 11.67% | 11.10% | 11.53% | 7.13% | 0.53% | 9.63% | 1.69% | 11.74% | 8.86% | 7.77% | 3.52% | 2.71% |
JNGLX Janus Henderson Global Life Sciences Fund | 4.74% | 4.56% | 5.84% | 4.26% | 0.25% | 9.85% | 7.80% | 6.23% | 13.32% | 0.89% | 0.30% | 8.81% |
Drawdowns
JACNX vs. JNGLX - Drawdown Comparison
The maximum JACNX drawdown since its inception was -66.81%, which is greater than JNGLX's maximum drawdown of -59.00%. Use the drawdown chart below to compare losses from any high point for JACNX and JNGLX.
Loading graphics...
Drawdown Indicators
| JACNX | JNGLX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -66.81% | -59.00% | -7.81% |
Max Drawdown (1Y)Largest decline over 1 year | -14.27% | -9.68% | -4.59% |
Max Drawdown (5Y)Largest decline over 5 years | -30.32% | -22.21% | -8.11% |
Max Drawdown (10Y)Largest decline over 10 years | -40.25% | -27.37% | -12.88% |
Current DrawdownCurrent decline from peak | -10.45% | -6.62% | -3.83% |
Average DrawdownAverage peak-to-trough decline | -14.76% | -17.73% | +2.97% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.92% | 3.61% | +1.31% |
Volatility
JACNX vs. JNGLX - Volatility Comparison
Janus Henderson Contrarian Fund (JACNX) has a higher volatility of 9.08% compared to Janus Henderson Global Life Sciences Fund (JNGLX) at 5.98%. This indicates that JACNX's price experiences larger fluctuations and is considered to be riskier than JNGLX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| JACNX | JNGLX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.08% | 5.98% | +3.10% |
Volatility (6M)Calculated over the trailing 6-month period | 15.52% | 10.63% | +4.89% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.75% | 17.86% | +6.89% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.89% | 15.69% | +6.20% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 21.69% | 17.42% | +4.27% |